Phase I study of intravenous ribavirin treatment of respiratory syncytial virus pneumonia after marrow transplantation.
Current Language EN
English English Türkçe Türkçe Español Español Português Português Pусский Pусский Filipino Filipino Tiếng Việt Tiếng Việt हिन्दी हिन्दी العربية العربية বাংলা বাংলা Deutsch Deutsch 中文 中文

Phase I study of intravenous ribavirin treatment of respiratory syncytial virus pneumonia after marrow transplantation.

D M Lewinsohn, R A Bowden, D Mattson, S W Crawford;D M Lewinsohn;R A Bowden;D Mattson;S W Crawford;
Antimicrobial agents and chemotherapy 1996 Vol. 40 pp. 2555-
171
crawford1996antimicrobialphase

Abstract

Respiratory syncytial virus (RSV) pneumonia in marrow transplant recipients is associated with significant mortality. Ribavirin is a nucleoside analog with activity against RSV and in its aerosolized formulation is the only drug approved for treatment ...

Keywords

Access

URL:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC163574...

Citation

ID: 112552
Ref Key: crawford1996antimicrobialphase
Use this key to autocite in SciMatic or Thesis Manager

References

References

No Bibliography

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
112552
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet
Gas fees required in SCI Coins
Buy SCI

Saymatik Web3.0 Wallet

Google Play
App Store